University of Texas M. D. Anderson Cancer Center Jun 30 2026 Reviewed Researchers from The University of Texas MD Anderson Cancer Center demonstrated that an artificial intelligence (AI)-based analysis of tumor biopsies can predict responses to immunotherapy in a study of patients with rare cancers, published in the Journal for ImmunoTherapy of Cancer. Led by Aung Naing, M.D., professor of Investigational Cancer Therapeutics, this analysis builds on recently published research that identified